Skip to main content
Premium Trial:

Request an Annual Quote

Looking for the Back Door

Chemical and pharmaceutical conglomerate Solvay is looking for a way out of the pharma business, reports the Wall Street Journal. The Belgian company said yesterday that it is looking into "various options for its pharmaceutical activities" including "discussions with third parties." The WSJ estimates that the pharmaceutical division could be worth $6.6 billion and says that potential buyers include Abbott Laboratories, AstraZeneca, Bayer, Merck KGaA of Germany, and Sanofi-Aventis.

The Scan

Alzheimer's Risk Gene Among Women

CNN reports that researchers have found that variants in MGMT contribute to Alzheimer's disease risk among women but not men.

Still Hanging Around

The Guardian writes that persistent pockets of SARS-CoV-2 in the body could contribute to long COVID.

Through a Little Spit

Enteric viruses like norovirus may also be transmitted through saliva, not just the fecal-oral route, according to New Scientist.

Nature Papers Present Method to Detect Full Transcriptome, Viruses Infecting Asgard Archaea, More

In Nature this week: VASA-seq approach to detect full transcriptome, analysis of viruses infecting Asgard archaea, and more.